(Q41053696)

26 September 2017

Effects of cardiovascular drugs on ATPase activity of P-glycoprotein in plasma membranes and in purified reconstituted form (English)

1 reference

26 September 2017

J F Rebbeor

1

1 reference

PubMed ID

9528676

26 September 2017

A E Senior

series ordinal

2

1 reference

26 September 2017

1 February 1998

1 reference

Biochimica et Biophysica Acta

26 September 2017

1 reference

26 September 2017

1369

1 reference

26 September 2017

85-93

1 reference

26 September 2017

1

1 reference

Biochemistry of multidrug resistance mediated by the multidrug transporter

26 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

P-glycoprotein--a mediator of multidrug resistance in tumour cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

Altered drug translocation mediated by the MDR protein: direct, indirect, or both?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

Biophysical aspects of P-glycoprotein-mediated multidrug resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

ABC Transporters: From Microorganisms to Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

The role of drug-lipid interactions in the biological activity of modulators of multi-drug resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

Characterization of the ATPase activity of P-glycoprotein from multidrug-resistant Chinese hamster ovary cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

The catalytic cycle of P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

Drug-stimulated ATPase activity of the human P-glycoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

Both P-glycoprotein nucleotide-binding sites are catalytically active

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

Characterization of the ATPase activity of purified Chinese hamster P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

The use of ion-exchange resins for studying ion transport in biological systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

Inorganic and organic phosphate measurements in the nanomolar range

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

The conformational behaviour of the cardiac glycoside digoxin as indicated by NMR spectroscopy and molecular dynamics calculations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

Quinidine Elimination in Patients with Congestive Heart Failure or Poor Renal Function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

Pharmacokinetics of diltiazem in patients with unstable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

Identification of P-glycoprotein in renal brush border membranes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

Substantial excretion of digoxin via the intestinal mucosa and prevention of long-term digoxin accumulation in the brain by the mdr 1a P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

Effects of steroids and verapamil on P-glycoprotein ATPase activity: progesterone, desoxycorticosterone, corticosterone and verapamil are mutually non-exclusive modulators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

Effects of lipids on ATPase activity of purified Chinese hamster P-glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

Interaction of bioactive hydrophobic peptides with the human multidrug transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2736%2897%2900185-5

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0005-2736(97)00185-5

1 reference

26 September 2017

1 reference

PubMed ID

9528676